Blog
Momentum Life Sciences Named a 2026 PM360 Trailblazer Awards Finalist in Two Categories
Momentum Life Sciences has been named a finalist in two categories of the 2026 PM360 Trailblazer Awards, recognizing innovative work and impact across the life sciences industry.
Welcome Tina Gafford, Director of Client Solutions
With more than 30 years of experience across nursing, specialty pharmacy, HUB operations, consulting, and patient services strategy, Tina Gafford joins Momentum Life Sciences as Director of Client Solutions.
Meeting Patients Where They Are: Why Trust Matters
Patient support programs have steadily expanded , adding more channels, more touchpoints, and more digital tools designed to keep patients informed and on therapy. But the experience patients describe often tells a different story. Despite the investments in personalization tools, channel optimization, and deep analytics around engagement, many patients report feeling less connected to their support program over time, not more.
The Front-End Shift: Prioritizing Dedicated Patient Engagement Beyond Hub and Specialty Pharmacy
Much of today's patient support is structured around the prescription — access, fulfillment, logistics. But some of the moments that most influence whether a patient initiates, adheres, and persists tend to happen somewhere else entirely: in the space between the prescription and the patient.
From Logistics to Relationship: Reimagining Patient Engagement Through Empathy and Connection
Data shows empathy-driven support leads to 30% better adherence. Learn to integrate AI and nurse educators to build trust-based patient relationships.
Redefining the Patient Journey in the Age of DTC
A quiet revolution is reshaping how therapies reach patients — and it’s happening faster than anyone expected. The pharmaceutical industry is experiencing a transformative shift towards Direct-to-Consumer (DTC) models, driven by several legislative and regulatory changes.
Where Human Expertise Meets AI: Advancing Patient Engagement
Artificial intelligence (AI) has advanced rapidly in its ability to understand language and detect emotion, giving pharmaceutical manufacturers powerful tools to scale and customize patient engagement. But AI on its own can’t deliver the kind of empathetic support patients truly need.
Three Pillars of Rare Disease Support: Building an Essential Network
Discover the three essential pillars of rare disease support: medical expertise, community connections, and family engagement. Learn how integrating these elements creates comprehensive support networks for the 1 in 1,500 Americans affected by rare diseases.